How I treat blastic plasmacytoid dendritic cell neoplasm
Blastic plasmacytoid dendritic cell neoplasm is a rare but aggressive malignancy that arises from precursors of plasmacytoid dendritic cells and typically
Related Articles
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
Context.—. Standardized bone marrow reporting specifically for myelodysplastic syndromes/neoplasms (MDS) is currently lacking in the literature and much needed in practice.Objective.—. To propose a standardized…
An Evidence-Based Approach to Climate Change and Health
This JAMA Insights discusses the need to fully assimilate evidence from observed and projected effects of climate change on health and invest in developing and…
Rush to Crush Cancer
Exciting Update: Rush to Crush Ca ncer has moved to a new fundraising platform for 2025! This means that if you previously participated in one…
Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitors
There are now multiple Bruton tyrosine kinase (BTK) inhibitors available, all sharing the common mechanism of blocking enzymatic activity, while exhibiting
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study
PURPOSEHuman epidermal growth factor receptor 2 (HER2) alterations occur in many solid cancers, including non–small cell lung cancer (NSCLC). Beamion LUNG-1 (ClinicalTrials.gov identifier: NCT04886804) is…
Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia
Key PointsInati-cel can induce high and durable responses in patients with R/R B-ALL, with a best ORR of 85.4% and a median DOR of 20.7 months.At…
Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study
Published in Leukemia & Lymphoma (Ahead of Print, 2025)
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski / BCMA-negative myeloma, cancer, CAR-T therapy, Guixiang Wang, Jiahuan Chen, Jianqing Mi,
Reform MP Rupert Lowe hits back at party leadership after losing whip
MP accused of threatening party chair says dealing with leadership is like smashing his head against a brick wall
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study – PubMed
QuestionThe performance of artificial intelligence-based medical tools for prostate MRI has yet to be evaluated on multi-centre, multi-vendor data to assess generalisability. FindingsA dedicated AI…
